ArticleScientific reports2025
Modeling the functionalized genistein-hyoscyamine derivatives.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Functionalized Fullerene Nanomaterials: Evaluating Heteroatom Identity for Enhanced Charge-Transfer and Reactivity.Molecules (Basel, Switzerland) · 2026Article
- Modeling and experimental analyses for Chitosan/Zinc oxide nanocomposite.Scientific reports · 2026Article
- DFT insights into humic acid coordination of Cd(II) Cu(II) and Pb(II).Scientific reports · 2026Article
- Investigating the electronic properties of graphene oxide functionalized with benzoic acid.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Due to the significant rise in demand for functional foods and health-conscious alternatives, natural extracts present a promising avenue for exploration and application within the food processing sector. For many individuals suffering from monosymptomatic nocturnal enuresis (MNE) and its accompanying complications, supplying the market with a functional food that aids accelerating resolving this problem will be a very valuable addition. Thus, in this study we aimed to validate and functionalize modeled composite of Genistein-Hyoscyamine as to further employ the best match in food processing sector as a novel food-additive for functional-foods serving enuretic patients. In attempts to model the most chemically favorable and experimentally achievable composite structures we thoroughly studied the parent molecules employing various DFT descriptors, selected electronic and thermodynamic parameters that help foresee and assess the structures' behavior and stability in various conditions that are common during food processing. Afterwards, composites were primarily assessed through selected ADME parameters in regard to their suitability for ingestion, water solubility, GI absorption, bioavailability score, and synthetic accessibility. Based on the screening of modeled structures, composites number 02 and 04 were found to possess the most favorable structures and characteristics where composite number 02 has shown relatively higher band gap energy and dipole moment as well as slightly more heat capacity; while composite number 04 has shown higher lipophilicity as well as lower TPSA value, less enthalpy, free energy, and entropy, suggesting more stability and bioavailability. Highlighting their suitability for being introduced to food matrices as food-additives in the form of composite bioactive materials.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.